Carl Yeung is the founder of Immvira. Immvira has raised $91M in total funding. Based in Shenzhen, China.
Carl Yeung is the Chief Financial Officer at Immvira, a biotechnology company focused on developing new generation oncolytic viruses for cancer therapeutics. With over 20 years of experience in capital markets, finance, and management of publicly listed companies, he has successfully led four Chinese technology companies through IPOs on NASDAQ, NYSE, and the Hong Kong Stock Exchange. He joined Immvira on July 1, 2020.
Full founder directory · Investor directory · Company funding database · Fundraising library